Simplified equity change report (Sano Investment-updated version)
Simplified equity change report (Chuanfa Investment)
Announcement on the progress of the controlling shareholder\'s proposed agreement to transfer part of the company\'s shares
Announcement on plans for shareholders holding 5% or more of the shares to reduce their holdings
Simplified Equity Change Report (Chuanfa Relief Fund)
Simplified equity change report (Sano Investment)
An indicative announcement regarding changes in the controlling shareholder\'s intention to transfer part of the company\'s shares and interests by agreement
Legal Opinion of Junlan Law Firm Shanghai regarding Adjustments, Cancellation, and Attribution of Restricted Stock Incentive Plan Award Prices for Chengdu Shengnuo Biotechnology Co., Ltd. in 2023.
Board of supervisors' opinion on the verification of the first and reserved grant allocation list for the 2023 restricted stock incentive plan.
Announcement on the first and reserved grants of the 2023 restricted stock incentive plan for the first vesting period in which the attribution conditions are satisfied.
Announcement on the Adjustment of the Grant Price of Restricted Stock Incentive Plan for 2023.
Notice regarding the cancellation of part of the 2023 restricted stock incentive plan that has been awarded but has not yet been allocated.
Announcement of Annual Equity Distribution Implementation in 2023
Announcement on the listing and circulation of part of the initial public offering of restricted shares
Announcement of the 2023 Annual Profit Distribution Plan
Announcement on the results of shareholders holding 5% or more of the shares reducing their shareholding
Announcement on terminating the issuance of shares to specific targets through simplified procedures in 2023
Chengdu Shengnuo Biotechnology Co., Ltd.\'s 2023 Stock Issuance Plan to Specific Targets Using Simple Procedures (Revised Draft)
Verification and Analysis Report on Chengdu Shengnuo Biotechnology Co., Ltd.\'s 2023 Stock Issuance Plan to Specific Targets Using Simple Procedures (Revised Draft)
Chengdu Shengnuo Biotechnology Co., Ltd.\'s 2023 Feasibility Analysis Report on Issuing Shares to Specific Targets Using Simple Procedures to Raise Funds (Revised Draft)
No Data
No Data